Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | Zendy

Jamie Lopez Bernal | Zendy; Nick Andrews | Zendy; Charlotte Gower | Zendy; Eileen Gallagher | Zendy; Ruth Simmons | Zendy; Simon Thelwall | Zendy; Julia Stowe | Zendy; Elise Tessier | Zendy; Natalie Groves | Zendy; Gavin Dabrera | Zendy; Richard Myers | Zendy; Colin Campbell | Zendy; Gayatri Amirthalingam | Zendy; Matt Edmunds | Zendy; Maria Zambon | Zendy; Kevin Brown | Zendy; Susan Hopkins | Zendy; Meera Chand | Zendy; Mary Ramsay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Author(s) -

Jamie Lopez Bernal,

Nick Andrews,

Charlotte Gower,

Eileen Gallagher,

Ruth Simmons,

Simon Thelwall,

Julia Stowe,

Elise Tessier,

Natalie Groves,

Gavin Dabrera,

Richard Myers,

Colin Campbell,

Gayatri Amirthalingam,

Matt Edmunds,

Maria Zambon,

Kevin Brown,

Susan Hopkins,

Meera Chand,

Mary Ramsay

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2108891

Subject(s) - vaccination , medicine , covid-19 , confidence interval , virology , disease , outbreak , infectious disease (medical specialty)

The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in the United Kingdom. The effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against this variant has been unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research